FILANA THERAPEUTICS Trademark

Trademark Overview

On Monday, January 19, 2026, a trademark application was filed for FILANA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the FILANA THERAPEUTICS trademark a serial number of 99602139. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, May 20, 2026. This trademark is owned by Cassava Sciences, Inc.. The FILANA THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical research services; Scientific research; Providing medical and scientific research information; Medical and scientific research in the field of neurologic and neuropsychiatric disorders, neurodegenerative diseases and developmental disorders, and in the fields of oncologic diseases, metabolic diseases, and pain; Pharmaceutical research and development; Pharmaceutical product evaluation; Technical consulting in the field of pharmaceutical studies; Laboratory research services relating to pharmaceuticals; Testing of pharmaceuticals; Laboratory services for the production of pharmaceuticals in the nature of pharmaceuticals for treating neurologic and neuropsychiatric disorders, neurodegenerative diseases and developmental disorders, and for treating oncologic diseases, metabolic diseases, and pain, and pharmaceuticals as analgesic preparations and preparations for pain relief

Pharmaceutical advice; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing medical information; Providing medical information in the field of neurologic and neuropsychiatric disorders, neurodegenerative diseases and developmental disorders, and in the fields of oncologic diseases, metabolic diseases, and pain

Pharmaceutical preparations for the treatment of neurologic and neuropsychiatric disorders, neurodegenerative diseases and developmental disorders, and for the treatment of oncologic diseases, metabolic diseases, and pain; Analgesic preparations; Preparation for the relief of pain
filana therapeutics

General Information

Serial Number99602139
Word MarkFILANA THERAPEUTICS
Filing DateMonday, January 19, 2026
Status680 - APPROVED FOR PUBLICATION
Status DateWednesday, May 20, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesMedical research services; Scientific research; Providing medical and scientific research information; Medical and scientific research in the field of neurologic and neuropsychiatric disorders, neurodegenerative diseases and developmental disorders, and in the fields of oncologic diseases, metabolic diseases, and pain; Pharmaceutical research and development; Pharmaceutical product evaluation; Technical consulting in the field of pharmaceutical studies; Laboratory research services relating to pharmaceuticals; Testing of pharmaceuticals; Laboratory services for the production of pharmaceuticals in the nature of pharmaceuticals for treating neurologic and neuropsychiatric disorders, neurodegenerative diseases and developmental disorders, and for treating oncologic diseases, metabolic diseases, and pain, and pharmaceuticals as analgesic preparations and preparations for pain relief
Goods and ServicesPharmaceutical advice; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing medical information; Providing medical information in the field of neurologic and neuropsychiatric disorders, neurodegenerative diseases and developmental disorders, and in the fields of oncologic diseases, metabolic diseases, and pain
Goods and ServicesPharmaceutical preparations for the treatment of neurologic and neuropsychiatric disorders, neurodegenerative diseases and developmental disorders, and for the treatment of oncologic diseases, metabolic diseases, and pain; Analgesic preparations; Preparation for the relief of pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 19, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 19, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 19, 2026
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCassava Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78731
US

Trademark Events

Event DateEvent Description
Monday, January 19, 2026NEW APPLICATION ENTERED
Monday, January 19, 2026APPLICATION FILING RECEIPT MAILED
Wednesday, January 21, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 15, 2026ASSIGNED TO EXAMINER
Wednesday, May 20, 2026EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 20, 2026EXAMINERS AMENDMENT E-MAILED
Wednesday, May 20, 2026EXAMINER'S AMENDMENT ENTERED
Wednesday, May 20, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 20, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

therapeutics filana diseases disorders pharmaceuticals research pain pharmaceutical medical developmental oncologic preparations